Search Within

Omar Ibrahim Abdel-Wahab

Formats
  1. Journal Article (301)
  2. Meeting Abstract (218)
  3. Review (19)
  4. Editorial (17)
  5. Research Letter (8)
  6. Book Section (7)
  7. Miscellaneous (2)
  8. Correspondence (1)
Groups
  1. Center for Hematologic Malignancies (573)
  2. Department of Medicine (573)
  3. Executive Committee, Center for Hematologic Malignancies (573)
  4. GSK Faculty (573)
  5. Hematologic Malignancies, Division of (573)
  6. Tow Center for Developmental Oncology (TCDO) (573)

More Groups

People
  1. Ross Levine (166)
  2. Benjamin Durham (83)
  3. Eli Diamond (72)
  4. Martin Tallman (68)
  5. Raajit Rampal (64)
  6. Young Rock Chung (47)

More People

Years
  1. 2025 (10)
  2. 2024 (26)
  3. 2023 (50)
  4. 2022 (42)
  5. 2021 (39)
  6. 2020 (33)

More Years

Publications
  1. Blood (183)
  2. Leukemia (29)
  3. Cancer Cell (22)
  4. Cancer Research (16)
  5. Haematologica (15)
  6. Pediatric Blood and Cancer (15)

More Publications

Publishers
  1. American Society of Hematology (197)
  2. Nature Publishing Group (83)
  3. Cell Press (47)
  4. American Association for Cancer Research (41)
  5. Ferrata Storti Foundation (15)
  6. Wiley Periodicals, Inc (15)

More Publishers

Results (573)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Distinct DNA methylation and expression profiles underlie CMML responsiveness to decitabine and uncover novel mechanism of resistance
    Meeting Abstract

    Meldi, K.; Qin, T. T.; Buchi, F.; Micol, J. B.; Sotzen, J.; Masala, E.; Allione, B.; Gioia, D.; Poloni, A.; Lunghi, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • High dose daunorubicin improves survival in AML up to age 60, across all cytogenetic Risk groups including patients with unfavorable cytogenetic risk, and FLT3-ITD mutant AML: Updated analyses from Eastern Cooperative Oncology trial E1900
    Meeting Abstract

    Luskin, M. R.; Lee, J. W.; Fernandez, H. F.; Lazarus, H. M.; Rowe, J. M.; Tallman, M. S.; Paietta, E. M.; Litzow, M.; Abdel-Wahab, O.; Patel, J. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Results of the ECOG E1900 trial in younger adults with AML using an event free survival endpoint are concordant with results based on overall survival: Potential for a surrogate endpoint to facilitate rapid approval of therapies in AML
    Meeting Abstract

    Luskin, M. R.; Lee, J. W.; Fernandez, H. F.; Lazarus, H. M.; Rowe, J. M.; Tallman, M. S.; Paietta, E. M.; Litzow, M.; Abdel-Wahab, O.; Patel, J. P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • SRSF2 mutations impair hematopoietic differentiation by altering exonic splicing enhancer preference
    Meeting Abstract

    Kim, E.; Ilagan, J. O.; Lee, S.; Ramakrishnan, A.; Chung, Y. R.; Micol, J. B.; Murphy, M. E.; Kim, M. K.; Zebari, A. S.; Feala, J.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS
    Meeting Abstract

    Inoue, D.; Matsui, H.; Hou, H. A.; Chou, W. C.; Nagamachi, A.; Kitaura, J.; Kawabata, K. C.; Togami, K.; Nagase, R.; Horikawa, S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Prospective blinded study of BRAFV600E mutation detection in cell-free DNA of patients with systemic histiocytic disorders
    Meeting Abstract

    Hyman, D. M.; Diamond, E.; Vibat, C. R.; Hassaine, L.; Poole, J.; Patel, M.; Holley, V.; Cabrilo, G.; Lu, T. T.; Arcila, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • The efficacy of vemurafenib in Erdheim-Chester disease and Langerhans cell histiocytosis: Preliminary results from VE-basket study
    Meeting Abstract

    Hyman, D. M.; Diamond, E.; Subbiah, V.; Blay, J. Y.; Lockhart, A. C.; Abdel-Wahab, O.; Sirzén, F.; Veronese, M. L.; Laserre, S. F.; Elez, E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Clinical utility of comprehensive profiling of genomic alterations in hematologic malignancies
    Meeting Abstract

    He, J.; Bufill, J. A.; Nahas, M. K.; Wang, K.; Young, L. E.; Knapp, K. M.; Brennan, K. W.; Donahue, A. L.; Young, G.; Ross, J. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Conditional loss of Dnmt3a results in myeloproliferation and liver-specific myeloid expansion
    Meeting Abstract

    Guryanova, O. A.; Lieu, Y.; Shank, K. R.; Rivera, S.; Garrett-Bakelman, F. E.; Glass, J.; Keller, M. D.; Pandey, S.; Tovbin, D.; Weinstein, A. R.; more...
    Blood (2014)

    Fulltext@MSK | Save